Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice
Headache: The Journal of Head and Face Pain · 2026-07 · 66 (7) · 1657-1659
DOI: 10.1111/head.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 14.06.2026. Verfasst von Sait Ashina. Beteiligte Einrichtung: Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Sait Ashina
Zitieren
APA
Ashina, S. (2026). Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain, 66(7), 1657-1659. https://doi.org/10.1111/head.70151
Vancouver
Ashina S. Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain. 2026;66(7):1657-1659. doi:10.1111/head.70151
BibTeX
@article{Ashina2026,
author = {Ashina, Sait},
title = {Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {7},
pages = {1657--1659},
doi = {10.1111/head.70151}
}
EUVIMED